Persistent B-cell depletion after rituximab for thrombocytopenic purpura

被引：6
|
作者：
Bisogno, Gianni [1 ]
机构：
[1] Univ Hosp Padova, Dept Pediat, Div Hematol Oncol, I-35128 Padua, Italy
来源：
EUROPEAN JOURNAL OF PEDIATRICS | 2007年 / 166卷 / 01期
关键词：
chronic immune thrombocytopenic purpura; rituximab; children; B-cell immunodeficiency;
D O I：
10.1007/s00431-006-0222-0
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [41] Thrombotic thrombocytopenic purpura with severe neurological impairment: remission after Rituximab
    Magalini, F.
    Stella, A.
    Basaglia, M.
    Vescovini, R.
    Sassi, M.
    Lombardi, A. Maria
    Sansoni, P.
    TRANSFUSION MEDICINE, 2011, 21 (02) : 140 - 143
  • [42] CLINICAL VALUE OF B-CELL ACTIVATING FACTOR RECEPTOR IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
    El-Neanaey, W. Ahmed
    BONE MARROW TRANSPLANTATION, 2014, 49 : S441 - S441
  • [43] PROLONGED B-CELL DEPLETION IN MuSK MYASTHENIA GRAVIS FOLLOWING RITUXIMAB TREATMENT
    Yi, John S.
    DeCroos, Emily C.
    Sanders, Donald B.
    Weinhold, Kent J.
    Guptill, Jeffrey T.
    MUSCLE & NERVE, 2013, 48 (06) : 992 - 993
  • [44] Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
    da Costa, Rita Quelhas
    Elena Aguirre-Alastuey, M.
    Isenberg, David A.
    Saracino, Amanda M.
    JAMA DERMATOLOGY, 2018, 154 (12) : 1432 - 1440
  • [45] Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura
    Becerra, E.
    Scully, M. A.
    Leandro, M. J.
    Heelas, E. O.
    Westwood, J. -P.
    De La Torre, I.
    Cambridge, G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 179 (03): : 414 - 425
  • [46] B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
    Jacob M van Laar
    Arthritis Research & Therapy, 12
  • [47] B-cell depletion therapy using rituximab in neuromyelitis optica spectrum disorders
    Kim, H. J.
    Kim, W.
    Park, M. S.
    Ha, C. K.
    Jung, I. J.
    Lee, K. I.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S253 - S254
  • [48] B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
    van Laar, Jacob M.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
  • [49] B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia
    Zaja, F
    Iacona, I
    Masolini, P
    Russo, D
    Sperotto, A
    Prosdocimo, S
    Patriarca, F
    Regazzi, M
    Baccarani, M
    Fanin, R
    de Vita, S
    HAEMATOLOGICA, 2002, 87 (02) : 189 - 195
  • [50] B-cell depletion with rituximab - a targeted therapy for Graves' disease and autoimmune thyroiditis
    Hasselbalch, HC
    IMMUNOLOGY LETTERS, 2003, 88 (01) : 85 - 86
12345